Isoniazid Market to Hit USD 976.6 Million, Globally, by 2031 at 5.9% CAGR
Pune, Maharashtra, India, November 10 2022 (Wiredrelease) Prudour Pvt. Ltd --:Isoniazid Market to Flourish with an Estimated Value of USD 976.6 Million by 2031 The Isoniazid Market is estimated to grow at a CAGR of 5.9% from 2022 to 2031 to reach USD 976.6 million by 2031. Isoniazid is used for the treatment of tuberculosis and is the first-line therapy for latent tuberculosis infection (LTBI). It is also used as an immunostimulant. The rise in the incidence of tuberculosis and the increase in government initiatives to control the spread of tuberculosis are the major factors driving the growth of the…
- Date: November 10, 2022
- Author: Quintero
- Category: PharmiWeb